Q3 2025 Charles River Laboratories International Inc Earnings Call Transcript

Nov 5, 2025 / 02:00 PM GMT

Release Date Price: €171.55

Transcript 10-Q8-K

Key Points

Positve

Charles River Laboratories International Inc (CRL) reported a slight outperformance in the third quarter, with revenue slightly exceeding the outlook provided in August.
The company is focusing on strategic actions to drive long-term shareholder value, including strengthening its portfolio through M&A partnerships and internal development efforts.
CRL is implementing initiatives designed to drive process improvement and greater operating efficiencies, expected to generate incremental net cost savings of approximately $70 million annually by 2026.
The company has a new $1 billion stock repurchase authorization, indicating a commitment to returning value to shareholders.
CRL is seeing signs of stabilization in client demand, with improved biotech funding and proposal activity in the third quarter, suggesting a potential rebound in demand.

Negative

CRL reported a 0.5% decrease in revenue year over year for the third quarter of 2025, with an organic revenue decline of 1.6%.
The operating margin decreased by 20 basis points year over year, driven by lower sales volume in the DSA segment and lower commercial CDMO revenue in the manufacturing segment.
Earnings per share declined by 6.2% from the third quarter of last year, with a significant headwind from the tax rate due to new tax legislation.
The DSA segment experienced a 3.1% year-over-year decrease in revenue on an organic basis, driven by lower revenue for both discovery and safety assessment services.
There is still some uncertainty in CRL's end markets, leading the company to remain cautious and focused on strong execution to drive further wallet share gains with clients.

Refinitiv StreetEvents Event Transcript
P R E L I M I N A R Y V E R S I O N

CRL.N - Charles River Laboratories International Inc
Q3 2025 Charles River Laboratories International Inc Earnings Call
Nov 05, 2025 / 02:00PM GMT

=====================
Conference Call Participants
=====================
* >>NOTE
* >>Transcription Start

=====================
Presentation
--------------------------------------------------------------------------------
>>NOTE [1]
--------------------------------------------------------------------------------

THIS TRANSCRIPT IS THE INITIAL PRELIMINARY VERSION WHICH LEVERAGES MACHINE LEARNING TECHNOLOGY. AS SUCH, PLEASE BE AWARE THERE MAY BE INACCURACIES IN THE TEXT DISPLAYED. FUTURE EDITED VERSIONS WILL BE REVIEWED FOR GREATER ACCURACY.

--------------------------------------------------------------------------------
>>Transcription Start, [2]
--------------------------------------------------------------------------------

Please stand by.

Your program is about to begin. If you need

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.